Literature DB >> 28363120

Awareness and understanding of HIV non-disclosure case law among people living with HIV who use illicit drugs in a Canadian setting.

Sophie Patterson1, Angela Kaida2, Gina Ogilvie3, Robert Hogg1, Valerie Nicholson2, Sabina Dobrer4, Thomas Kerr5, Jean Shoveller5, Julio Montaner5, M-J Milloy6.   

Abstract

BACKGROUND: In 2012, the Supreme Court of Canada (SCC) ruled that people living with HIV (PLWH) could face criminal charges if they did not disclose their serostatus before sex posing a "realistic possibility" of HIV transmission. Condom-protected vaginal sex with a low (i.e., <1500copies/mL) HIV viral load (VL) incurs no duty to disclose. Awareness and understanding of this ruling remain uncharacterized, particularly among marginalized PLWH.
METHODS: We used data from ACCESS, a community-recruited cohort of PLWH who use illicit drugs in Vancouver. The primary outcome was self-reported awareness of the 2012 SCC ruling, drawn from cross-sectional survey data. Participants aware of the ruling were asked how similar their understanding was to a provided definition. Sources of information from which participants learned about the ruling were determined. Multivariable logistic regression identified factors independently associated with ruling awareness.
RESULTS: Among 249 participants (39% female), median age was 50 (IQR: 44-55) and 80% had a suppressed HIV VL (<50copies/mL). A minority (112, 45%) of participants reported ruling awareness, and 44 (18%) had a complete understanding of the legal obligation to disclose. Among those aware (n=112), newspapers/media (46%) was the most frequent source from which participants learned about the ruling, with 51% of participants reporting that no healthcare providers had talked to them about the ruling. Ruling awareness was negatively associated with VL suppression (AOR:0.51, 95% CI:0.27,0.97) and positively associated with recent condomless sex vs. no sex (AOR:2.00, 95% CI:1.03,3.92).
CONCLUSION: Most participants were not aware of the 2012 SCC ruling, which may place them at risk of prosecution. Discussions about disclosure and the law were lacking in healthcare settings. Advancing education about HIV disclosure and the law is a key priority. The role of healthcare providers in delivering information and support to PLWH in this legal climate should be further explored.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Antiretroviral therapy; Canada; Criminalization; HIV; HIV disclosure; Illicit drug use; Supreme Court of Canada

Mesh:

Substances:

Year:  2017        PMID: 28363120      PMCID: PMC5811265          DOI: 10.1016/j.drugpo.2017.02.003

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  31 in total

1.  Imputation of missing longitudinal data: a comparison of methods.

Authors:  Jean Mundahl Engels; Paula Diehr
Journal:  J Clin Epidemiol       Date:  2003-10       Impact factor: 6.437

2.  Prevalence and predictors of facing a legal obligation to disclose HIV serostatus to sexual partners among people living with HIV who inject drugs in a Canadian setting:a cross-sectional analysis.

Authors:  Sophie Patterson; Angela Kaida; Paul Nguyen; Sabina Dobrer; Gina Ogilvie; Robert Hogg; Thomas Kerr; Julio Montaner; Evan Wood; M-J Milloy
Journal:  CMAJ Open       Date:  2016-04-28

3.  HIV transmission, the Law and the work of the clinical team, January 2013.

Authors:  Matthew Phillips; Mary Poulton
Journal:  Int J STD AIDS       Date:  2013-09-18       Impact factor: 1.359

4.  Expanded highly active antiretroviral therapy coverage among HIV-positive drug users to improve individual and public health outcomes.

Authors:  Julio S G Montaner; Evan Wood; Thomas Kerr; Viviane Lima; Rolando Barrios; Kate Shannon; Richard Harrigan; Robert Hogg
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

5.  Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver.

Authors:  D M Patrick; S A Strathdee; C P Archibald; M Ofner; K J Craib; P G Cornelisse; M T Schechter; M L Rekart; M V O'Shaughnessy
Journal:  Int J STD AIDS       Date:  1997-07       Impact factor: 1.359

6.  Narratives of HIV: measuring understanding of HIV and the law in HIV-positive patients.

Authors:  Matthew D Phillips; Gabriel Schembri
Journal:  J Fam Plann Reprod Health Care       Date:  2015-01-14

7.  HIV transmission law in the age of treatment-as-prevention.

Authors:  Bridget Haire; John Kaldor
Journal:  J Med Ethics       Date:  2015-09-29       Impact factor: 2.903

8.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Authors:  Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall
Journal:  Lancet       Date:  2010-07-16       Impact factor: 79.321

9.  Incarceration of people living with HIV/AIDS: implications for treatment-as-prevention.

Authors:  M-J Milloy; Julio S G Montaner; Evan Wood
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

Review 10.  A documentation policy development proposal for clinicians caring for people living with HIV/AIDS.

Authors:  Alyssa Bryan; Patrick O'Byrne
Journal:  Policy Polit Nurs Pract       Date:  2012-05
View more
  2 in total

1.  Community healthcare workers' experiences with the care of clients on antiretroviral therapy in the community.

Authors:  Mygirl Pearl Lowane; Hilda Nwamuhohova Shilubane; Rachel Tsakani Lebese
Journal:  Pan Afr Med J       Date:  2022-02-10

2.  Perspectives of HIV-positive and -negative people who use drugs regarding the criminalization of HIV non-disclosure in Canada: a qualitative study.

Authors:  Cara Ng; Koharu Loulou Chayama; Andrea Krüsi; Will Small; Rod Knight
Journal:  BMC Public Health       Date:  2020-08-10       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.